A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.

Moritz Mirna; Vera Paar; Albert Topf; Theo Kraus; Karl Sotlar; Achim Aigner; Alexander Ewe; Simon Watzinger; Bruno K Podesser; Matthias Hackl; Rudin Pistulli; Uta Hoppe; Attila Kiss; Michael Lichtenauer

doi:10.1093/cvr/cvab015

A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.

Moritz Mirna^* (Erstautor/-in), Vera Paar (Co-Autor/-in), Albert Topf (Co-Autor/-in), Theo Kraus (Co-Autor/-in), Karl Sotlar (Co-Autor/-in), Achim Aigner, Alexander Ewe, Simon Watzinger, Bruno K Podesser, Matthias Hackl, Rudin Pistulli, Uta Hoppe (Co-Autor/-in), Attila Kiss, Michael Lichtenauer (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

15 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	556-572
Fachzeitschrift	CARDIOVASCULAR RESEARCH
Jahrgang	118
Ausgabenummer	2
DOIs	https://doi.org/10.1093/cvr/cvab015
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1093/cvr/cvab015

Dieses zitieren

Mirna, M., Paar, V., Topf, A., Kraus, T., Sotlar, K., Aigner, A., Ewe, A., Watzinger, S., Podesser, B. K., Hackl, M., Pistulli, R., Hoppe, U., Kiss, A., & Lichtenauer, M. (2022). A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis. CARDIOVASCULAR RESEARCH , 118(2), 556-572. https://doi.org/10.1093/cvr/cvab015

Mirna, Moritz ; Paar, Vera ; Topf, Albert et al. / A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis. in: CARDIOVASCULAR RESEARCH 2022 ; Jahrgang 118, Nr. 2. S. 556-572.

@article{9d255db4ec344505a0cc97fafe0b004a,

title = "A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.",

keywords = "MICRORNA, CARDIOMYOPATHY, EXPRESSION, MANAGEMENT, DISEASE",

author = "Moritz Mirna and Vera Paar and Albert Topf and Theo Kraus and Karl Sotlar and Achim Aigner and Alexander Ewe and Simon Watzinger and Podesser, {Bruno K} and Matthias Hackl and Rudin Pistulli and Uta Hoppe and Attila Kiss and Michael Lichtenauer",

note = "Mirna; Paar; Topf; Lichtenauer; Hoppe: Department of Cardiology, University Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria; Kraus; Sotlar: University Institute ofPathology, Paracelsus Medical University of Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria;",

year = "2022",

doi = "10.1093/cvr/cvab015",

language = "English",

volume = "118",

pages = "556--572",

journal = "CARDIOVASCULAR RESEARCH ",

issn = "0008-6363",

number = "2",

}

Mirna, M , Paar, V, Topf, A, Kraus, T , Sotlar, K, Aigner, A, Ewe, A, Watzinger, S, Podesser, BK, Hackl, M, Pistulli, R, Hoppe, U, Kiss, A & Lichtenauer, M 2022, 'A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.', CARDIOVASCULAR RESEARCH , Jg. 118, Nr. 2, S. 556-572. https://doi.org/10.1093/cvr/cvab015

A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis. / Mirna, Moritz (Erstautor/-in); Paar, Vera (Co-Autor/-in); Topf, Albert (Co-Autor/-in) et al.
in: CARDIOVASCULAR RESEARCH , Jahrgang 118, Nr. 2, 2022, S. 556-572.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.

AU - Mirna, Moritz

AU - Paar, Vera

AU - Topf, Albert

AU - Kraus, Theo

AU - Sotlar, Karl

AU - Aigner, Achim

AU - Ewe, Alexander

AU - Watzinger, Simon

AU - Podesser, Bruno K

AU - Hackl, Matthias

AU - Pistulli, Rudin

AU - Hoppe, Uta

AU - Kiss, Attila

AU - Lichtenauer, Michael

N1 - Mirna; Paar; Topf; Lichtenauer; Hoppe: Department of Cardiology, University Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria; Kraus; Sotlar: University Institute ofPathology, Paracelsus Medical University of Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, Austria;

PY - 2022

Y1 - 2022

KW - MICRORNA

KW - CARDIOMYOPATHY

KW - EXPRESSION

KW - MANAGEMENT

KW - DISEASE

U2 - 10.1093/cvr/cvab015

DO - 10.1093/cvr/cvab015

M3 - Original Article

C2 - 33483746

SN - 0008-6363

VL - 118

SP - 556

EP - 572

JO - CARDIOVASCULAR RESEARCH

JF - CARDIOVASCULAR RESEARCH

IS - 2

ER -

Mirna M , Paar V, Topf A, Kraus T , Sotlar K, Aigner A et al. A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis. CARDIOVASCULAR RESEARCH . 2022;118(2):556-572. doi: 10.1093/cvr/cvab015